v3.26.1
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Net Former Parent Investment [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2024     $ 3,066     $ 31,049 $ 34,115
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net Income (loss)     0     3,976 3,976
Net decrease in Net Former Parent Investment     (3,066)     (1,988) (5,054)
Change in foreign currency translation adjustments             0
Balance at Jun. 30, 2025     $ 0     33,037 33,037
Beginning balance at Dec. 31, 2025             $ 0
Beginning balance (in shares) at Dec. 31, 2025             0
Increase (Decrease) in Temporary Equity [Roll Forward]              
Issuance of Series G Preferred Shares             $ 4,236
Issuance of Series G Preferred Shares (in shares)             4,236
Deemed dividend on Issuance of Series G Preferred Shares (Note 11)             $ 635
Ending balance at Jun. 30, 2026             $ 4,871
Ending balance (in shares) at Jun. 30, 2026             4,236
Balance at Dec. 31, 2025 $ 1 $ 0   $ 14,036 $ 0 31,761 $ 45,798
Balance (in shares) at Dec. 31, 2025 100,000 1,542          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net Income (loss)       0 0 (1,092) (1,092)
Excess Consideration over acquired assets $ 0 $ 0   (24,335) 403 0 (23,932)
Change in foreign currency translation adjustments 0 0   0 (165) 0 (165)
Deemed dividend on Series G Preferred Shares issuance (Note 11) 0 0   0 0 (635) (635)
Dividends of preferred shares (Note 11) 0 0   0 0 (183) (183)
Equity issuance costs (Note 9) 0 0   (1,806) 0 0 (1,806)
Fractional shares 0 $ 0   0 0 0 0
Fractional shares (in shares)   (22)          
Deemed dividend on warrant Inducement 0 $ 0   0 0 (26) (26)
Incremental fair value of the Class C warrants 0 0   26 0 0 26
Issuance of common stock including the exercise of warrants (Note 9) 0 $ 6   32,494 0 0 32,500
Issuance of common stock including the exercise of warrants (Note 9) (in shares)   603,492          
Balance at Jun. 30, 2026 $ 1 $ 6   $ 20,415 $ 238 $ 29,825 $ 50,485
Balance (in shares) at Jun. 30, 2026 100,000 605,012